Literature DB >> 20584919

Ethical analysis of withdrawing ventricular assist device support.

Paul S Mueller1, Keith M Swetz, Monica R Freeman, Kari A Carter, Mary Eliot Crowley, Cathy J Anderson Severson, Soon J Park, Daniel P Sulmasy.   

Abstract

OBJECTIVE: To describe a series of patients with heart failure supported with a ventricular assist device (VAD) who requested (or whose surrogates requested) withdrawal of VAD support and the legal and ethical aspects pertaining to these requests. PATIENTS AND METHODS: We retrospectively reviewed the medical records of patients at Mayo Clinic, Rochester, MN, from March 1, 2003, through January 31, 2009, who requested (or whose surrogates requested) withdrawal of VAD support and for whom the requests were fulfilled. We then explored the legal and ethical permissibility of carrying out such requests.
RESULTS: The median age of the 14 patients identified (13 men, 1 woman) was 57 years. Requests were made by 2 patients and 12 surrogates. None of the patients' available advance directives mentioned the VAD. For 11 patients, multidisciplinary care conferences were held before withdrawal of VAD support. Only 1 patient had an ethics consultation. All 14 patients died within 1 day of withdrawal of VAD support.
CONCLUSION: Patients have the right to refuse or request the withdrawal of any unwanted treatment, and we argue that this right extends to VAD support. We also argue that the cause of death in these cases is the underlying heart disease, not assisted suicide or euthanasia. Therefore, patients with heart failure supported with VADs or their surrogates may request withdrawal of this treatment. In our view, carrying out such requests is permissible in accordance with the principles that apply to withdrawing other life-sustaining treatments.

Entities:  

Mesh:

Year:  2010        PMID: 20584919      PMCID: PMC2931614          DOI: 10.4065/mcp.2010.0113

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  19 in total

1.  Withdrawing very low-burden interventions in chronically ill patients.

Authors:  J A Rhymes; L B McCullough; R J Luchi; T A Teasdale; N Wilson
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

2.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

3.  Assisted suicide: the philosophers' brief.

Authors:  Ronald Dworkin; Thomas Nagel; Robert Nozick; John Rawls; Thomas Scanlon; Judith Jarvis Thomson
Journal:  New York Rev Books       Date:  1997-03-27

4.  Securing patients' right to refuse medical care: in praise of the Cruzan decision.

Authors:  E J Emanuel
Journal:  Am J Med       Date:  1992-03       Impact factor: 4.965

5.  Ethics manual: fifth edition.

Authors:  Lois Snyder; Cathy Leffler
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

6.  Discontinuing an implantable cardioverter defibrillator as a life-sustaining treatment.

Authors:  T E Quill; S S Barold; B L Sussman
Journal:  Am J Cardiol       Date:  1994-07-15       Impact factor: 2.778

7.  Seven legal barriers to end-of-life care: myths, realities, and grains of truth.

Authors:  A Meisel; L Snyder; T Quill
Journal:  JAMA       Date:  2000-11-15       Impact factor: 56.272

8.  Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.

Authors:  Paul S Mueller; C Christopher Hook; David L Hayes
Journal:  Mayo Clin Proc       Date:  2003-08       Impact factor: 7.616

9.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

10.  Killing and allowing to die: another look.

Authors:  D P Sulmasy
Journal:  J Law Med Ethics       Date:  1998       Impact factor: 1.718

View more
  28 in total

1.  Beware of mereologists bearing gifts: prolegomena to a medical metaphysics.

Authors:  George Khushf
Journal:  Theor Med Bioeth       Date:  2013-10

Review 2.  Palliative care and end-of-life issues in patients treated with left ventricular assist devices as destination therapy.

Authors:  Keith M Swetz; Abigale L Ottenberg; Monica R Freeman; Paul S Mueller
Journal:  Curr Heart Fail Rep       Date:  2011-09

3.  Little hope for medical futility.

Authors:  Arthur L Caplan
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

Review 4.  Ethical dilemmas surrounding the use of ventricular assist devices in supporting patients with end-stage organ dysfunction.

Authors:  Courtenay R Bruce; Baruch Brody; Mary A Majumder
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

5.  Palliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy-Challenges to Measuring Impact and Change in Institutional Culture.

Authors:  Brandon P Verdoorn; Angela J Luckhardt; Sara E Wordingham; Shannon M Dunlay; Keith M Swetz
Journal:  J Pain Symptom Manage       Date:  2017-01-16       Impact factor: 3.612

6.  Dying With a Left Ventricular Assist Device as Destination Therapy.

Authors:  Shannon M Dunlay; Jacob J Strand; Sara E Wordingham; John M Stulak; Angela J Luckhardt; Keith M Swetz
Journal:  Circ Heart Fail       Date:  2016-10       Impact factor: 8.790

7.  Caring for a spouse with end-stage heart failure through implantation of a left ventricular assist device as destination therapy.

Authors:  Lisa A Kitko; Judith E Hupcey; Juliann H Gilchrist; John P Boehmer
Journal:  Heart Lung       Date:  2013-03-14       Impact factor: 2.210

Review 8.  [Ethics in intensive care and euthanasia : With respect to inactivating defibrillators at the end of life in terminally ill patients].

Authors:  H-J Trappe
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-11-17       Impact factor: 0.840

9.  End-of-life discontinuation of destination therapy with cardiac and ventilatory support medical devices: physician-assisted death or allowing the patient to die?

Authors:  Mohamed Y Rady; Joseph L Verheijde
Journal:  BMC Med Ethics       Date:  2010-09-15       Impact factor: 2.652

Review 10.  The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.

Authors:  Jörg Carlsson; Norbert W Paul; Matthias Dann; Jörg Neuzner; Dietrich Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2012-08-20       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.